Product Manager
Sandra Forbes
A Novel Approach to Monomer Production for Ophthalmic Uses
High-purity monomers serve as essential raw materials in the manufacturing of ophthalmic products. Chemical impurities, or even fluctuations in the impurity profile, can adversely affect both the safety and comfort of contact lens wearers. Adding complexity to the supply chain, scaling up production from laboratory-scale to full-scale reactors can be challenging. Moreover, these products are often inherently unstable, resulting in a limited shelf life. This drawback complicates lean manufacturing efforts at both monomer and contact lens production facilities.
The pursuit of enhanced monomer quality is constrained by cost limitations, as consumers are shifting towards daily disposable lenses instead of weekly or monthly options; consequently, the demand for raw materials will continue to rise. New chemical production methods that enhance manufacturing economics while simultaneously improving purity are required to make contact lenses more affordable. The innovation must deliver:
· Flexibility to produce a variety of products on a single manufacturing line
· Reduced likelihood of batch failures
· Optimized yields and purity levels
· Guaranteed consistency over several decades
Most monomer synthesis production routes utilize conventional batch methods. These processes involve introducing and mixing starting materials in a single vessel, followed by a series of operations such as heating/cooling, reaction, distillation, crystallization, separation, and/or drying. The equipment is cleaned after each production cycle since the same equipment must accommodate a wide range of chemicals. Although these strategies are well-established, they do not always provide the flexibility, scalability, and reliability needed to meet the specific demands of the contact lens industry. Limitations in batch manufacturing, such as inadequate mixing and prolonged reaction times for heating and cooling, can result in suboptimal outcomes or even batch failure.
Continuous Flow Manufacturing offers a practical and robust solution for producing high-purity monomers for ophthalmic applications. We possess extensive experience with this technology, both at the small-scale laboratory level and for global production of critical raw materials with an unparalleled level of quality.
Components of a Continuous Flow Reactor System
Continuous flow manufacturing (CFM) leverages miniaturization and reactor design geometry to overcome constraints encountered in certain batch processes. In its most basic configuration, CFM employs a compact reactor setup that facilitates intimate mixing and precise temperature control, thereby eliminating the need for extended heating or cooling periods. Furthermore, the small reactor volume (typically just a few milliliters) results in short reaction times (often measured in seconds) and minimal side reactions. In addition to providing a cost-effective alternative to batch manufacturing, CFM offers superior risk mitigation through precise process control and effectively eliminates the risk of large-scale batch failures.
CFM reactors are based on a network of long, narrow tubes that create an advantageous volume-to-surface-area ratio. Efficient mixing within this geometry is typically achieved through various methods, such as narrow channels and static mixing elements. The narrow tubes that constitute the reactor are typically enclosed by a heat exchange fluid that circulates around each "reactor" to maintain precise temperature control.
Pumps, feed mixing devices, and collection/work-up units complete the reaction setup. Figures 1 & 2 depict this design for simple reactors used in typical organic/polymer reactions.
Figures 1 & 2. Components of a Continuous Flow Reactor
CFM reactors can be easily tailored for small-scale production (up to several kilograms per day) by selecting appropriate materials of construction and heating/cooling mechanisms. One company has developed specialized equipment capable of scaling up to kilo-level synthesis, offering a broad spectrum of functionalities (as illustrated in Figures 3 & 4). This includes manufacturing processes customized to meet the specific demands of the contact lens industry.
Figures 3 & 4. CFM reactors
Examples of Monomer Synthesis by Continuous Flow
Acryloyl chloride serves as a crucial precursor for numerous directly derived acrylate polymers utilized in ophthalmic and other applications. As depicted in the figure below, it also functions as a foundational component for intermediate acrylate monomers, which are ultimately transformed into polymers employed in contact lens production. Each of these materials can be synthesized with high efficiency using Continuous Flow Manufacturing (CFM). Although we have traditionally supplied these monomers in limited quantities, the adoption of CFM technology now allows us to fulfill the scale, purity, and bulk pricing requirements of industrial customers.
Typical Reactions Performed by CFM
· Polymer Chemistry
– Monomers for Biomedical Applications
– Reagents for Polymer Synthesis (e.g. RAFT reagents)
· Pharmaceutical and Organic Chemistry
– Pharmaceutical Intermediates (non-GMP)
– Reagents and catalysts (e.g. chiral catalysts, fluorinating reagents)
· Materials Science
– Nanoparticle Synthesis
· Specialized Reactions
– Reactions involving hazardous species (e.g. azides, diazoacetates, cyanides)
– Stenches
Characteristics of Reactions Suited for CFM
While Continuous Flow Manufacturing (CFM) offers numerous advantages, not all chemical reactions are optimally positioned to leverage these enhancements. Reactions that are particularly well-suited for CFM exhibit the following characteristics:
· Reactions that necessitate high temperatures or cryogenic conditions, which can restrict scalability in batch processes.
· High-volume products that demand multiple production runs in traditional plant settings.
· Reactions involving sensitive or unstable chemical species.
· Reactions that entail the use of hazardous materials.
Aladdinsci: https://www.aladdinsci.com